Moderna Elliot Wave CorrectionI believe that Moderna ($MRNA) is in the middle of an Elliot Wave Corrective Pattern. It seems to be rising up in the middle of the B of the ABC correction.
Price Target = Around $170 near January 1st, 2022.
MRNA trade ideas
✅MODERNA RESISTANCE AHEAD|SHORT🔥
✅MODERNA is making a rebound
And will soon retest the resistance
From where a pullback is likely
With the target being the recent low
SHORT🔥
✅Like and subscribe to never miss a new idea!✅
Moderna ShortMRNA ABC Correction Pattern.
Seems Moderna in a harsh dead cat bounce right now that is being buoyed by the booster authorization.
Short-Term target at 190.
$MRNA Jiego's Full Cycle RSI Framework$MRNA latest ... held point 4 (RSI 43s support) of the Jiego's Full Cycle RSI Framework .. Looking at Point 5.
MRNA trying to bottom out hereMRNA is bouncing off what use to be its top trend line resistance in 2021.
when a stock is bullish and resistance breaks, that resistance should turn into support when the stock dips again. I believe thats what is happening here on MRNA, also notice how the RSI bounced around this exact area plenty of times this year? my price targets are 355/390 before another pullback.
666 by END OF NOVEMBER - MURDERNA (MRNA)5th Wave on Moderna, possible 666 in the next month, while accumulating now. Thoughts?
$MRNA Moderna relief Bounce trade
Hopefully you find the chart helpful in terms of Supports & Resistance etc.
we refrain from adding commentary on the chart as that is reserved for our members and we are very conscious of not giving financial or trading advice.
Thank you for taking time to consult our chart and we would really appreciate a like, follow or comment.
Buy MRNA 13/10/2021You can buy MRNA target 447.6 stop loss 272.3
Money management your responsibility.
I recommend entering a maximum of 10% of the portfolio. Good luck
Start of the new move ?I am liking the move up with MRNA today and i think we are getting started for the leg up. Initiated a small position.
Stocks - MRNA Short (S3) Aug 13 TargetIdea for MRNA:
- Good level for reversal. Aug 13 is the capitulation date.
- Stop is at 41 degrees.
- Gamma squeeze bubble ends with big deflation.
TP1: Gap fill 260~
PT 0.5 retrace of move:
GLHF
- DPT
$MRNA Spring is getting loadedBullish Spring load.
Decreasing volume at around 375-400 shows more gas to boost the rocket up.
Moderna sliding back to Earth. MRNAPivot on a huge impulse fractal confirmed. We are drawing more and more zigzags from now on. Our goals are shown.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
Moderna Short Selling CallAfter bullish trend and a distribution phase it is expected that bearish trend would be followed.
Short selling would be advised.
Entry position mentioned in charts
MRNACountries halting, one product, rich PE, break of ascending triangle last week and failed to close above down trend today..
MRNAModerna broke weekly support making this very vulnerable towards 237-250$/share.
Will fall pretty hard in coming days - weeks iMO.
Overvalued af in the high 400's nearly cut in half but not quite yet .. currently in puts.
MRNA is Bullish Here (Drop is Overextended). Expect a Rally.Moderna (MRNA) is Bullish Here. Drop is Overextended Volatility Wise. Expect a Rally.
Moderna & the Downfall Moderna end extand fith wave and will go Bearish son to 200$ provided that it does not close above levels 444
What May Happen to Moderna and Pfizer?International pharmaceutical giant Merck & Co announced the successful end of its clinical trial of the world’s first oral COVID-19 antiviral drug molnupiravir in the simple form of a pill. The company has claimed that molnupiravir effectively decreases the risk of hospitalization and death of sick individuals who have just contracted the virus or have advanced symptoms by half.
Moreover, the company also suggested that molnupiravir could be used to prevent the contraction of the coronavirus. But what is most important at this stage is that fact that the clinical trials of molnupiravir showed high effectiveness against different COVID-19 variants, including the terrifying Delta variant. This seems to be good news for antivaxers or for anybody who is looking for an alternative prevention method from COVID-19 other than the vaccine.
Whether you agree or disagree with having the vaccine, it is worthwhile to consider this information as a means of expanding your investment portfolio with Merck stocks. Additionally, COVID-19 major vaccine producers Pfizer and Moderna stocks may suffer if the new pill is officially registered.
Let’s take a look at Pfizer and Moderna’s price charts.
Both stocks suffered a 50% correction from their peaks in August. Although, Pfizer business model is more diversified than that of Moderna’s, the technical picture shows that the upward trend for Pfizer stocks is more in danger. The reason for such fears is that over the last three consecutive trading sessions its stocks closed below the trend support line that started in February 2021. So, if Pfizer stock prices fail to recover above the $43.20-44 correction, they are likely to continue towards the $38.20-39.20 area. In this area, two important technical lines cross – one is the support line of the upward trend that started in March 2020 and the second – former resistance line that connects September 2020 and May, June 2021 highs. Pfizer and BioNTEch may have a trump of positive opinion by the Committee for Medicinal Products for Human Use (CHMP) for the administration of the Pfizer-BioNTech COVID-19 vaccine as a booster shot six months after the second dose, but this factor is already priced in.
The Moderna stock prices chart seems to be more complex as it shows that the March 2020 long-term upward trend is supported by the upward trend that started in May 2021 in the area of $319-321. Even the correction from the peak of $496.71 closely echoes the ABC correction structure, where A and C waves are equal. And if so, Moderna stocks may recover both not only to recent highs, but to new all-time highs. Such a scenario might be activated if prices hold above the downward channel from August 10. In this case new targets may open at $563-565.
Technical perspectives of Merck stocks will be reviewed in the coming comments.
A Potential LowAppears to be a quite clear ABC correction and the pitchfork has mapped it nicely, id say there is a good chance the bottom may be in here.
